Development and validation of a new antenatal warning score system (DRRiP) for neonatal complications of gestational diabetes

Abstract

A common trend across the world is rising levels of gestational diabetes mellitus (GDM) and the worldwide pooled prevalence (regardless of differing diagnostic thresholds) currently stands at 4.4%. 1The upward trend is fast becoming a major health problem [2][3][4] and is thought to be partly explained by advancing maternal age and increasing rates of obesity. 5 Prevalence rates of GDM are higher in ethnic minority populations and there is a well-recognized positive association between ever increasing racial diversity in western populations and rates of GDM.